Her primary areas of study are Genetics, Haplotype, Single-nucleotide polymorphism, Genome-wide association study and Linkage disequilibrium. Her study in Genetics is interdisciplinary in nature, drawing from both Amyotrophic lateral sclerosis, Charged multivesicular body protein 2B and TARDBP. Her Charged multivesicular body protein 2B research is multidisciplinary, relying on both C9orf72 Protein, DNA Repeat Expansion, C9orf72 and Trinucleotide repeat expansion.
Sonja W. Scholz interconnects Exome sequencing and UBQLN2 in the investigation of issues within TARDBP. Her research integrates issues of Genetic variability and Disease, Parkinson's disease in her study of Single-nucleotide polymorphism. Her work investigates the relationship between Genetic variation and topics such as Allele frequency that intersect with problems in LRRK2 and Genetic heterogeneity.
Her main research concerns Genetics, Disease, Genome-wide association study, Parkinson's disease and Single-nucleotide polymorphism. Her study in Amyotrophic lateral sclerosis extends to Genetics with its themes. The concepts of her Disease study are interwoven with issues in Gene, Cohort and Genetic architecture.
Sonja W. Scholz interconnects Genetic variability, Dementia with Lewy bodies, Genetic association, Age of onset and Heritability in the investigation of issues within Genome-wide association study. Her work carried out in the field of Single-nucleotide polymorphism brings together such families of science as Odds ratio and Bioinformatics. Her Haplotype research includes themes of Charged multivesicular body protein 2B, TARDBP and C9orf72 Protein, DNA Repeat Expansion, Trinucleotide repeat expansion.
Sonja W. Scholz mainly focuses on Disease, Parkinson's disease, LRRK2, Bioinformatics and Progressive supranuclear palsy. Her research in Disease intersects with topics in Computational biology, Gene, Cohort study and Cohort. Her Cohort study research is multidisciplinary, incorporating perspectives in Amyotrophic lateral sclerosis, Genotyping, Case-control study and TARDBP.
Her work in Cohort covers topics such as Single-nucleotide polymorphism which are related to areas like Oncology. Her Bioinformatics research incorporates elements of Genetic risk, Proteostasis, Locus, Regulation of gene expression and Tauopathy. Her Dementia research is multidisciplinary, relying on both Genetics, Alpha-synuclein, Glucocerebrosidase, Huntingtin and Etiology.
Sonja W. Scholz mostly deals with Disease, LRRK2, Parkinson's disease, Genome-wide association study and Lewy body. Her Disease study integrates concerns from other disciplines, such as RNA, Viral infection and Virology. Her LRRK2 research incorporates themes from Heterozygote advantage, Mutation, Confidence interval, Penetrance and Risk factor.
Her study in Parkinson's disease is interdisciplinary in nature, drawing from both Odds ratio and Oncology. Her studies deal with areas such as Progressive supranuclear palsy, Expression quantitative trait loci, Proportional hazards model, Hazard ratio and Cohort as well as Genome-wide association study. Sonja W. Scholz has included themes like Glucocerebrosidase, Genetics, Alpha-synuclein and Age of onset in her Lewy body study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD
Alan E. Renton;Elisa Majounie;Adrian James Waite;Javier Simón-Sánchez;Javier Simón-Sánchez.
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simón-Sánchez;Claudia Schulte;Jose M Bras;Jose M Bras;Manu Sharma.
Nature Genetics (2009)
Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS
Janel O. Johnson;Jessica Mandrioli;Michael Benatar;Yevgeniya Abramzon.
Genotype, haplotype and copy-number variation in worldwide human populations
Mattias Jakobsson;Sonja W. Scholz;Sonja W. Scholz;Paul A Scheet;J. Raphael Gibbs;J. Raphael Gibbs.
A genome-wide association study identifies protein quantitative trait loci (pQTLs).
David Melzer;John R. B. Perry;Dena Hernandez;Anna-Maria Corsi.
PLOS Genetics (2008)
Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data
Hon-Chung Fung;Hon-Chung Fung;Hon-Chung Fung;Sonja Scholz;Mar Matarin;Javier Simón-Sánchez;Javier Simón-Sánchez.
Lancet Neurology (2006)
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
Mike A Nalls;Cornelis Blauwendraat;Costanza L Vallerga;Karl Heilbron.
Lancet Neurology (2019)
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
Aude Nicolas;Kevin P. Kenna;Alan E. Renton;Alan E. Renton;Nicola Ticozzi.
SNCA Variants Are Associated with Increased Risk for Multiple System Atrophy
Sonja W. Scholz;Sonja W. Scholz;Henry Houlden;Claudia Schulte;Manu Sharma.
Annals of Neurology (2009)
Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study.
Hannu Laaksovirta;Terhi Peuralinna;Jennifer C Schymick;Sonja W Scholz;Sonja W Scholz.
Lancet Neurology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: